Vital Signs - Healthcare News - The Analysts Perspective - October Issue

Regular Price: USD 500.00

Special Price USD 450.00

10% OFF

* Required Fields

Regular Price: USD 500.00

Special Price USD 450.00


Be the first to review this product

This issue of Vital Signs, released on November 6, 2014, discusses Immucor's collaboration with Sirona Genomics, Becton Dickinson's acquisition of GenCell Biosystems, and an update on the Ebola virus.

Table of Contents

Vital Signs - Healthcare News - The Analyst's Perspective - October IssueVital Signs - October 2014This week's issue

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.